Table 5 Clinical complications
Adverse events | PPS | SS | ||||
|---|---|---|---|---|---|---|
1–2-3(n = 34) | 1–3-5(n = 34) | P1 | 1–2-3(n = 36) | 1–3-5(n = 38) | P2 | |
Steroid diabetes, n(%) | 2 (5.88%) | 0 | 0.493 | 3 (8.33%) | 1 (2.63%) | 0.351 |
Upper respiratory tract infection, n(%) | 0 | 1 (2.94%) | 1.000 | 0 | 2 (5.26%) | 0.494 |
Pneumonia, n(%) | 1 (2.94%) | 0 | 1.000 | 1 (2.78%) | 2 (5.26%) | 1.000 |
Herpes zoster, n(%) | 0 | 1 (2.94%) | 1.000 | 0 | 1 (2.63%) | 1.000 |
All, n(%) | 3 (8.82%) | 2 (5.88%) | 1.000 | 4 (11.11%) | 6 (15.79%) | 0.737 |